The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus

NCT06203275 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Paroxetine
DRUG: Placebo

Sponsor

aya ramadan ashmawy sarhan